Louis-David Cantin, Ph.D. - Publications

2000 Université de Montréal, Montréal, Canada 
chemistry of natural products

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Cantin LD, Bayrakdarian M, Buon C, Grazzini E, Hu YJ, Labrecque J, Leung C, Luo X, Martino G, Paré M, Payza K, Popovic N, Projean D, Santhakumar V, Walpole C, et al. Discovery of P2X3 selective antagonists for the treatment of chronic pain. Bioorganic & Medicinal Chemistry Letters. 22: 2565-71. PMID 22370269 DOI: 10.1016/j.bmcl.2012.01.124  0.483
2001 Hanessian S, Moitessier N, Cantin LD. Design and synthesis of MMP inhibitors using N-arylsulfonylaziridine hydroxamic acids as constrained scaffolds Tetrahedron. 57: 6885-6900. DOI: 10.1016/S0040-4020(01)00641-X  0.457
2000 Hanessian S, Griffin AM, Cantin LD. Asymmetric synthesis of functionalized carbocycles and heterocycles. Chirality. 12: 342-5. PMID 10824149 DOI: 10.1002/(Sici)1520-636X(2000)12:5/6<342::Aid-Chir7>3.0.Co;2-Y  0.437
2000 Hanessian S, Cantin LD. The synthesis of enantiomerically pure disubstituted aziridines and N- alkoxy aziridines Tetrahedron Letters. 41: 787-790. DOI: 10.1016/S0040-4039(99)02211-X  0.43
1999 Hanessian S, Cantin LD, Andreotti D. Total Synthesis and Absolute Configuration of (-)-Anthoplalone. The Journal of Organic Chemistry. 64: 4893-4900. PMID 11674567 DOI: 10.1021/Jo990302N  0.46
1998 Hanessian S, Cantin L. Synthesis and Biological Evaluation of Constrained Phosphonoglutamic Acids as Metabotropic Agents Molecules Online. 2: 46-52. DOI: 10.1007/S007830050054  0.465
1997 Hanessian S, Cantin L, Roy S, Andreotti D, Gomtsyan A. The synthesis of enantiomerically pure, symmetrically substituted cyclopropane phosphonic acids — A constrained analog of the GABA antagonist phaclophen Tetrahedron Letters. 38: 1103-1106. DOI: 10.1016/S0040-4039(96)02518-X  0.446
Show low-probability matches.